Studies showed that Sermorelin treatment in adults with GHD could increase IGF-1 levels, though not always to the same extent as GH replacement, and produce improvements in body composition (increased lean mass, reduced fat mass), energy levels, exercise capacity, and quality of life measures
However, these indicators typically reflect established structural injury or significant functional decline, resulting in delayed recognition of the disease relative to its underlying molecular onset [140, 141]
Some users employ aggressive front-loading approaches for acute injuries, starting with higher doses during the first week when the inflammatory response peaks
1B) with the 4T1 transcriptome and surprisingly revealed a positive correlation with several gene sets related to fatty acid (FA) biosynthesis and lipid metabolism (Fig